Sign Out
Pregnancy: There are no adequate and well-controlled studies of enoxaparin in pregnant women. However, available data in humans and animals indicate that enoxaparin does not cross the placenta and has not shown evidence of teratogenicity or fetotoxicity.
Breast-feeding: It is not known whether enoxaparin is distributed into milk; because many drugs are distributed into human milk and because of the potential for serious adverse reactions to enoxaparin in nursing infants, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the woman.
Fertility: No clinical data of enoxaparin sodium in fertility.
